| Completed | Ask Questions (ASQ):Implementation of a Communication Intervention NCT05025748 | Barbara Ann Karmanos Cancer Institute | N/A |
| Unknown | Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer NCT04670445 | Massachusetts General Hospital | N/A |
| Unknown | Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites NCT04267575 | Jerome Canady, M.D. | N/A |
| Completed | Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malig NCT03229278 | Rutgers, The State University of New Jersey | Phase 1 |
| Terminated | Afatinib in Advanced Refractory Urothelial Cancer NCT02122172 | University of Chicago | Phase 2 |
| Completed | Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer NCT03154190 | Stanford University | N/A |
| Terminated | Surgery With or Without Postoperative Intensity Modulated Radiation Therapy in Treating Patients With Urotheli NCT02316548 | NRG Oncology | Phase 2 |
| Completed | Sirolimus, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Bladder Cancer NCT01938573 | University of Washington | Phase 1 / Phase 2 |
| Completed | Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointe NCT01846520 | City of Hope Medical Center | N/A |
| Terminated | Adjuvant Radiation for High Risk Bladder Cancer NCT01954173 | Emory University | N/A |
| Terminated | Docetaxel and Lapatinib in Metastatic Transitional Cell Carcinoma in Bladder NCT01382706 | University of Southern California | Phase 2 |
| Terminated | Veliparib, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Biliary, Pancreatic, Ur NCT01282333 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Pazopanib in Treating Patients With Metastatic Urothelial Cancer NCT00471536 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Gemcitabine, Paclitaxel, Doxorubicin in Metastatic or Unresectable Bladder Cancer With Decreased Kidney Functi NCT00478361 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | VEGF Trap in Treating Patients With Recurrent, Locally Advanced, or Metastatic Cancer of the Urothelium NCT00407485 | National Cancer Institute (NCI) | Phase 2 |
| Terminated | Sorafenib in Treating Patients With Regional or Metastatic Cancer of the Urothelium NCT00112905 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Sorafenib in Treating Patients With Advanced or Metastatic Cancer of the Urinary Tract NCT00112671 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Efficacy of Combination of Trastuzumab to Gemcitabine - Platinum Advanced or Metastatic Urothelial Carcinoma NCT01828736 | Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie | Phase 2 |
| Terminated | Neoadjuvant Intravesical Vaccine Therapy in Treating Patients With Bladder Carcinoma Who Are Undergoing Cystec NCT00072137 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Phase II Trial Of PS-341 (Bortezomib) In Patients With Previously Treated Advanced Urothelial Tract Transition NCT00072150 | National Cancer Institute (NCI) | Phase 2 |
| Terminated | Trastuzumab in Treating Patients With Previously Treated, Locally Advanced, or Metastatic Cancer of the Urothe NCT00004856 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Decitabine in Treating Patients With Advanced Solid Tumors NCT00030615 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction NCT00030498 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Comparison of Immediate and Delayed Adjuvant Chemotherapy in Treating Patients Who Have Undergone a Radical Cy NCT00028756 | European Organisation for Research and Treatment of Cancer - EORTC | Phase 3 |
| Completed | Ixabepilone in Treating Patients With Advanced Urinary Tract Cancer NCT00021099 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Trastuzumab and Combination Chemotherapy in Treating Patients With Locally Recurrent or Metastatic Urinary Tra NCT00005831 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu NCT00004074 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Gene Therapy in Treating Patients With Advanced Bladder Cancer NCT00003167 | National Cancer Institute (NCI) | Phase 1 |
| Terminated | Antineoplastons A10 and AS2-1 In Patients With Carcinoma of the Bladder NCT00003452 | Burzynski Research Institute | Phase 2 |